Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nymox Pharmaceutical Corp.

www.nymox.com

Latest From Nymox Pharmaceutical Corp.

Finance Watch: In Obesity, Vivus Raises Cash For Deals, Orexigen Finds A Buyer

Public Company Edition: Strategies diverge in obesity as Vivus restructures debt and raises cash for a new deal and new focus, after Orexigen nears a sale of the company via bankruptcy court. Also, Clovis leads recent offerings, while layoffs are on the table at Catabasis.

Financing Business Strategies

Pipeline Watch: Phase III Progress With Biosimilar Adalimumab And Trastuzumab

Pipeline Watch has been updated to bring greater depth and detail to a potential therapeutic product’s progress through the R&D pipeline. The table brings you a snapshot of selected late-stage clinical trial events in the pharma and biotech industries.

Pipeline Watch Clinical Trials

PIPELINE WATCH: Progress In Lung And Prostate Cancer, But Interferon Disappoints In Asthma

Pipeline Watch has been updated to bring greater depth and detail to a potential therapeutic product’s progress through the R&D pipeline. The table brings you a snapshot of selected late-stage clinical trial events in the pharma and biotech industries.

Pipeline Watch Research & Development

Recordati Seeks Ex-Italy Growth In Orphan Drugs, Emerging Markets And OTCs

Italy’s Recordati plans to globalize its orphan drugs business and will target Russia, Turkey and markets in Central and Eastern Europe for its primary care prescription and OTC products.

BioPharmaceutical Asia Pacific
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Saliva-based Testing
    • Urine-based Testing
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Gynecological, Urological
  • Infectious & Viral Diseases
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Nymox Pharmaceutical Corp.
  • Senior Management
  • Erik Danielsen, CFO
    Paul Averback, MD, Pres.
    Brian Doyle, Dir., Bus. Dev.
  • Contact Info
  • Nymox Pharmaceutical Corp.
    Phone: (800) 936-9669
    777 Terrace Ave.
    3rd Fl.
    Hasbrouck Heights, NJ 07604
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register